Allogeneic adipose tissue-derived mesenchymal stem cell therapy (Taipei Medical University)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAllogeneic adipose tissue-derived mesenchymal stem cell therapy (Taipei Medical University)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Stem cell therapy > Adipose stem cell therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsKidney Failure, Chronic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTaiwan

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesTaipei Medical University

China Registration ClassN/A

Develop Information

Active CompaniesTaipei Medical University

Inactive CompaniesN/A

Active IndicationsKidney Failure, Chronic

Inactive IndicationsN/A

Other Information

ATC CodeN/A